In the case of PPARG, it has been extensively linked to MPNs, since its ligands promote the resolution of myelofibrosis in preclinical models [35] and seem to be crucial for the development of new therapeutic approaches for hematological malignancies [36]. The gene discussed is PPARG; the disease is myelofibrosis.